UOC
RXII

UBS O'Connor’s GALENA BIOPHARMA INC COM RXII Stock Holding History

UBS O'Connor’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,193,942
Closed -$1.66M – 1052
2015
Q1 		$1.66M Buy
+1,193,942
New +$1.66M 0.02% 447
2013
Q4 		– Sell
-349,400
Closed -$793K – 568
2013
Q3 		$793K Buy
+349,400
New +$793K 0.02% 308

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

UBS O'Connor's RXII Position: Q2 2015 in Review

UBS O'Connor sold out of GALENA BIOPHARMA INC COM (RXII) in Q2 2015, closing a stake of 1,193,942 shares — an estimated $1.66M sold.

UBS O'Connor first reported a position in RXII in Q3 2013 and held it in 2 quarters. The position peaked at $1.66M in Q1 2015. 86 funds tracked by Wall St. Rank hold RXII as of Q2 2015.

  • UBS O'Connor reported no remaining GALENA BIOPHARMA INC COM position as of Q2 2015 after selling out during the quarter.
  • UBS O'Connor sold 1,193,942 GALENA BIOPHARMA INC COM shares in Q2 2015, an estimated $1.66M.
  • UBS O'Connor first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 2 quarters.
  • UBS O'Connor's GALENA BIOPHARMA INC COM position peaked at $1.66M in Q1 2015.
  • 86 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.